Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129163) titled 'perioperative anticoagulation study' on July 31.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Fudan University Shanghai Cancer Center
Condition:
Primary and Metastatic Liver Cancer
Intervention:
Early Anticoagulation Group:Patients should begin subcutaneous injections of low-molecular-weight heparin calcium (nadroparin calcium injection) within 24 hours after surgery, at a fixed dose of 4,100 IU/0.4 mL once daily, continuing until discharge.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Early Anticoagulation Group:20...